Immunovia Publishes Interim Report for January-March 2023
LUND, Sweden, May 23, 2023 /PRNewswire/ — January-March 2023 Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). Net earnings were MSEK -51.7 (-44.1) and earnings per share before and after dilution were SEK -2.28 (-1.95). Cash Flow from operating activities were MSEK -39.7 (-46.1). … Read more